YU43551B - Process for obtaining new substituted pyrimidines - Google Patents

Process for obtaining new substituted pyrimidines

Info

Publication number
YU43551B
YU43551B YU1983/83A YU198383A YU43551B YU 43551 B YU43551 B YU 43551B YU 1983/83 A YU1983/83 A YU 1983/83A YU 198383 A YU198383 A YU 198383A YU 43551 B YU43551 B YU 43551B
Authority
YU
Yugoslavia
Prior art keywords
obtaining new
substituted pyrimidines
new substituted
pyrimidines
obtaining
Prior art date
Application number
YU1983/83A
Other languages
English (en)
Other versions
YU198383A (en
Inventor
S M Daluge
P M Skonezny
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of YU198383A publication Critical patent/YU198383A/xx
Priority to YU144288A priority Critical patent/YU46697B/sh
Publication of YU43551B publication Critical patent/YU43551B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
YU1983/83A 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines YU43551B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU144288A YU46697B (sh) 1980-11-11 1988-07-26 Postupak za dobijanje novih supstituisanih pirimidina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
YU198383A YU198383A (en) 1984-04-30
YU43551B true YU43551B (en) 1989-08-31

Family

ID=10517217

Family Applications (5)

Application Number Title Priority Date Filing Date
YU2663/81A YU42444B (en) 1980-11-11 1981-11-10 Process for obtaining new substituted pyrimidines
YU1983/83A YU43551B (en) 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines
YU01982/83A YU198283A (en) 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines
YU01981/83A YU198183A (en) 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines
YU144288A YU46697B (sh) 1980-11-11 1988-07-26 Postupak za dobijanje novih supstituisanih pirimidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU2663/81A YU42444B (en) 1980-11-11 1981-11-10 Process for obtaining new substituted pyrimidines

Family Applications After (3)

Application Number Title Priority Date Filing Date
YU01982/83A YU198283A (en) 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines
YU01981/83A YU198183A (en) 1980-11-11 1983-10-03 Process for obtaining new substituted pyrimidines
YU144288A YU46697B (sh) 1980-11-11 1988-07-26 Postupak za dobijanje novih supstituisanih pirimidina

Country Status (35)

Country Link
US (4) US4438267A (xx)
EP (1) EP0051879B1 (xx)
JP (1) JPS57114581A (xx)
KR (1) KR880001736B1 (xx)
AR (1) AR245447A1 (xx)
AU (1) AU549449B2 (xx)
CA (1) CA1186310A (xx)
CS (1) CS273153B2 (xx)
CY (1) CY1419A (xx)
DD (1) DD201896A5 (xx)
DE (1) DE3173752D1 (xx)
DK (1) DK172884B1 (xx)
EG (1) EG16107A (xx)
ES (5) ES8307759A1 (xx)
FI (1) FI76333C (xx)
GB (1) GB2087881B (xx)
GR (1) GR81317B (xx)
HK (1) HK23388A (xx)
HU (1) HU188762B (xx)
IE (1) IE52128B1 (xx)
IL (1) IL64256A (xx)
IT (1) IT1210589B (xx)
MC (1) MC1418A1 (xx)
MY (1) MY8600678A (xx)
NO (2) NO160137C (xx)
NZ (1) NZ198932A (xx)
PH (2) PH22654A (xx)
PL (4) PL139828B1 (xx)
PT (1) PT73960B (xx)
RU (1) RU1819264C (xx)
SG (1) SG62686G (xx)
SU (4) SU1424732A3 (xx)
YU (5) YU42444B (xx)
ZA (1) ZA817780B (xx)
ZM (1) ZM9481A1 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
WO1997020839A1 (en) * 1995-12-04 1997-06-12 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
EP1401413B1 (en) * 2001-06-29 2006-11-22 AB Science Use of tyrosine kinase inhibitions for treating allergic diseases
PT1401416E (pt) 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
WO2003002108A2 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
CA2452368A1 (en) * 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
US20040242601A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
US20040242612A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of tyrosine kinase inhibitors for promoting hair growth
DE60225590T2 (de) * 2001-09-20 2008-09-25 Ab Science C-kithemmer zur behandlung von bakteriellen infektionen
CA2531757A1 (en) * 2003-07-11 2005-01-20 Arpida Ag Benzofuran derivatives and their use in the treatment of microbial infections
AU2006215788B2 (en) * 2005-02-18 2011-10-20 Acino Pharma Ag Novel processes for the preparation of a 2H-chromene
BRPI0615613A2 (pt) * 2005-09-01 2009-05-19 Hoffmann La Roche diaminopirimidinas como moduladores de p2x3 e p3x2/3
WO2010003084A2 (en) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
CA2778931A1 (en) * 2009-06-12 2010-12-16 Marianne Allard Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2,4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2,4-(1h,3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
EP3981765A4 (en) * 2019-06-06 2023-05-31 Beijing Tide Pharmaceutical Co., Ltd. P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
WO2022217295A1 (en) * 2021-04-09 2022-10-13 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
EP0051879A2 (en) 1982-05-19
PL239279A1 (en) 1983-08-01
NO813804L (no) 1982-05-12
CS825781A2 (en) 1990-07-12
EP0051879B1 (en) 1986-02-05
IT8149676A0 (it) 1981-11-10
KR880001736B1 (ko) 1988-09-10
JPH0474351B2 (xx) 1992-11-26
SG62686G (en) 1987-03-27
KR830007628A (ko) 1983-11-04
ES506969A0 (es) 1983-07-01
DK172884B1 (da) 1999-09-06
ES8405380A1 (es) 1984-06-01
YU266381A (en) 1984-04-30
YU198183A (en) 1984-04-30
PT73960A (en) 1981-12-01
PH22654A (en) 1988-10-28
SU1424732A3 (ru) 1988-09-15
ES521201A0 (es) 1984-06-01
ES521202A0 (es) 1984-06-01
HK23388A (en) 1988-04-08
EP0051879A3 (en) 1982-08-04
GB2087881B (en) 1985-05-15
DE3173752D1 (en) 1986-03-20
PL233754A1 (en) 1983-08-01
JPS57114581A (en) 1982-07-16
GB2087881A (en) 1982-06-03
DD201896A5 (de) 1983-08-17
ES521204A0 (es) 1984-06-01
ZM9481A1 (en) 1983-11-21
FI813546L (fi) 1982-05-12
IE812631L (en) 1982-05-11
PT73960B (en) 1983-11-23
EG16107A (en) 1987-10-30
PL239280A1 (en) 1983-08-01
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
ZA817780B (en) 1983-06-29
MY8600678A (en) 1986-12-31
CY1419A (en) 1988-04-22
YU46697B (sh) 1994-04-05
AU549449B2 (en) 1986-01-30
NO160137B (no) 1988-12-05
SU1306473A3 (ru) 1987-04-23
PL139427B1 (en) 1987-01-31
NO1994029I1 (no) 1994-12-29
IE52128B1 (en) 1987-06-24
US4587342A (en) 1986-05-06
ES8307759A1 (es) 1983-07-01
FI76333B (fi) 1988-06-30
ES8405379A1 (es) 1984-06-01
YU42444B (en) 1988-08-31
PH25053A (en) 1991-01-28
US4761475A (en) 1988-08-02
GR81317B (xx) 1984-12-11
RU1819264C (ru) 1993-05-30
PL139523B1 (en) 1987-01-31
IT1210589B (it) 1989-09-14
ES8405378A1 (es) 1984-06-01
ES521203A0 (es) 1984-06-01
NZ198932A (en) 1985-05-31
DK496681A (da) 1982-05-12
US4438267A (en) 1984-03-20
PL239278A1 (en) 1983-08-01
YU198283A (en) 1984-04-30
IL64256A0 (en) 1982-02-28
MC1418A1 (fr) 1982-10-18
CS273153B2 (en) 1991-03-12
SU1318148A3 (ru) 1987-06-15
IL64256A (en) 1988-01-31
PL139827B1 (en) 1987-02-28
NO160137C (no) 1989-03-15
YU198383A (en) 1984-04-30
ES8405377A1 (es) 1984-06-01
YU144288A (en) 1990-04-30
US4603136A (en) 1986-07-29
HU188762B (en) 1986-05-28
SU1535379A3 (ru) 1990-01-07
PL139828B1 (en) 1987-02-28
AR245447A1 (es) 1994-01-31
FI76333C (fi) 1988-10-10

Similar Documents

Publication Publication Date Title
YU198183A (en) Process for obtaining new substituted pyrimidines
YU105383A (en) Process for obtaining 2-guanidino-4-heteroarylthiazoles
YU221581A (en) Process for obtaining isoxazolyl-benzamides
YU42734B (en) Process for obtaining new imidazolyl-pyridine
YU45076B (en) Process for obtaining new alphasulphonyloxiketone-acethale
YU164481A (en) Process for obtaining isoxazolyl-imidazolidinone
YU43996B (en) Process for making 2-mercaptoethylaminhydrohalide
PT73270A (en) Process for preparing novel pyrimidine serivatives
YU277781A (en) Process for obtaining new acylcarbamides
YU81181A (en) Process for obtaining substituted derivatives
YU80281A (en) Process for obtaining substituted triarylthiazole compounds
YU290481A (en) Process for preparing new pyrimidones
GB2089341B (en) Buspirone process
PT72378B (en) Process for preparing substituted benzoni-triles
YU193781A (en) Process for obtaining 11-hydroxy-13-oxa-prostaglandins
YU306781A (en) Process for obtaining new latam compounds
YU70881A (en) New process for obtaining new 2-haloacetamides
YU217981A (en) Process for obtaining 4-carbamoyloxy-oxaphosphorine
YU184881A (en) Process for obtaining 4-amino-12-dihydrocarbyl-pyrazolidine
YU71081A (en) Process for obtaining 2-haloacetamides
YU202080A (en) Process for preparing 2-methylthio-4-amino pyrimidines
GB2082160B (en) Process for obtaining senarmontite
YU42338B (en) Process for obtaining estradiol-17-polyphosphate
YU43219B (en) Process for obtaining l-lyzine
YU68280A (en) Process for obtaining n-alkyl-n-nitroso-urea